Upgrade to SI Premium - Free Trial

InflaRx N.V. (IFRX)

2.22 -0.01 (0.45%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/6/26)

Latest Headlines

InflaRx Announces Participation in September Investor Conferences August 20, 2026 7:30 AM - Globe NewsWire Form SCHEDULE 13G InflaRx N.V. Filed by: Commodore Capital LP August 17, 2026 4:34 PM - SEC Filing Form SCHEDULE 13G/A InflaRx N.V. Filed by: MONTANOVA CAPITAL, LLC August 14, 2026 4:31 PM - SEC Filing Form 424B5 InflaRx N.V. August 14, 2026 4:22 PM - SEC Filing Form SCHEDULE 13G InflaRx N.V. Filed by: Sirenia Capital Management LP August 14, 2026 8:35 AM - SEC Filing Form SCHEDULE 13G/A InflaRx N.V. Filed by: FARALLON CAPITAL MANAGEMENT, L.L.C. August 14, 2026 8:22 AM - SEC Filing Form EFFECT InflaRx N.V. August 13, 2026 6:06 AM - SEC Filing Inflarx NV (IFRX) PT Raised to $6 at Cantor Fitzgerald August 7, 2026 11:09 AM - StreetInsider Form SCHEDULE 13G InflaRx N.V. Filed by: FMR LLC August 6, 2026 10:29 AM - SEC Filing Form F-3 InflaRx N.V. August 6, 2026 9:21 AM - SEC Filing Form S-8 InflaRx N.V. August 6, 2026 9:19 AM - SEC Filing Form 6-K InflaRx N.V. For: Aug 06 August 6, 2026 7:56 AM - SEC Filing InflaRx N.V. (IFRX) Misses Q2 EPS by 2c August 6, 2026 7:33 AM - StreetInsider InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones August 6, 2026 7:30 AM - Globe NewsWire InflaRx to Report Second Quarter 2026 Results on August 6, 2026 July 30, 2026 7:30 AM - StreetInsider Form 6-K InflaRx N.V. For: Jun 30 June 30, 2026 4:05 PM - SEC Filing InflaRx reviews AAV strategy after EMA moves to revoke Tavneos June 30, 2026 7:31 AM - StreetInsider InflaRx Assessing Feasibility of Broadened Strategy for ANCA‑Associated Vasculitis in Europe Following EMA Recommendation on Tavneos June 30, 2026 7:30 AM - Globe NewsWire Full Article List